Genopole Call for Innovative Ideas

Apply before: October 31, 2023

Genopole Call for Innovative Ideas aims to foster groundbreaking concepts that can transform the future of medicine and improve patient care. Genopole seeks to identify and support innovative ideas that hold the potential to address pressing medical challenges, enhance diagnostics and treatment methods, and revolutionize the healthcare industry.

Eligibility

To be eligible for Genopole Call for Innovative Ideas you must:

You can apply to this call for applications solo OR as a team (max. 5), it’s up to you!

The idea must be realistic, medically acceptable, and technically feasible. It relies on your experience and know-how. Go beyond the stage of simple intuition!
All expenses contributing to the maturation of the idea and the implementation of the proof of concept are eligible, with the exception of the purchase of materials and equipment.

Benefits

The winners benefit from:

Financial support of up to €10,000 to establish a first proof of concept
Individualized support from GIP Genopole (help in finding scientific, technological, and industrial partners within the cluster, support in building the roadmap and identifying service providers, etc.)
Access to the Genopolitan network and technological platforms

The Value-Adding Paradox: How Spending Less Can Actually Make Your Business More Valuable?

Application Process

Click here to apply.

For more information click here.

For more Interesting Content and other Opportunities Visit and Follow/Like Us On Facebook,Twitter,LinkedIn, and Instagram

Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, The, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Burma, Burundi, Cambodia, Cameroon, Canada, Cabo Verde, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo, Cook Islands, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Curacao, Cyprus, Czechia, Denmark, Djibouti, Dominica, Dominican Republic, East Timor, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Fiji, Finland, France, Gabon, Gambia, The, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Holy See, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, North Korea, South Korea, Kosovo, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macau, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, North Macedonia, Norway, Oman, Pakistan, Palau, Palestinian Territories, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Sint Maarten, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Swaziland (See Eswatini), Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Yemen, Zambia, Zimbabwe